Hudson Value Partners LLC grew its holdings in The Procter & Gamble Company (NYSE:PG – Free Report) by 19.1% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,806 shares of the company’s stock after acquiring an additional 290 shares during the period. Hudson Value Partners LLC’s holdings in Procter & Gamble were worth $313,000 as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds have also modified their holdings of the stock. Itau Unibanco Holding S.A. acquired a new stake in shares of Procter & Gamble during the 2nd quarter worth about $28,000. Fairway Wealth LLC acquired a new stake in Procter & Gamble during the second quarter worth approximately $29,000. Ruedi Wealth Management Inc. lifted its position in shares of Procter & Gamble by 64.7% during the 1st quarter. Ruedi Wealth Management Inc. now owns 196 shares of the company’s stock worth $32,000 after buying an additional 77 shares during the last quarter. POM Investment Strategies LLC acquired a new position in shares of Procter & Gamble in the 2nd quarter valued at $34,000. Finally, Quest Partners LLC purchased a new position in shares of Procter & Gamble in the 2nd quarter valued at $36,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Price Performance
NYSE:PG opened at $163.41 on Friday. The firm has a market cap of $384.84 billion, a price-to-earnings ratio of 28.17, a price-to-earnings-growth ratio of 3.57 and a beta of 0.42. The Procter & Gamble Company has a 12-month low of $142.50 and a 12-month high of $177.94. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50. The company’s 50-day moving average is $171.29 and its two-hundred day moving average is $168.13.
Procter & Gamble Announces Dividend
The company also recently disclosed a quarterly dividend, which will be paid on Friday, November 15th. Stockholders of record on Friday, October 18th will be issued a dividend of $1.0065 per share. The ex-dividend date of this dividend is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a dividend yield of 2.46%. Procter & Gamble’s payout ratio is 69.48%.
Insider Buying and Selling
In other Procter & Gamble news, CEO Jon R. Moeller sold 37,240 shares of Procter & Gamble stock in a transaction that occurred on Wednesday, August 28th. The shares were sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the transaction, the chief executive officer now directly owns 263,537 shares of the company’s stock, valued at $44,508,763.93. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other Procter & Gamble news, insider Susan Street Whaley sold 450 shares of the company’s stock in a transaction that occurred on Tuesday, August 20th. The stock was sold at an average price of $169.22, for a total value of $76,149.00. Following the completion of the transaction, the insider now owns 13,072 shares in the company, valued at $2,212,043.84. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Jon R. Moeller sold 37,240 shares of Procter & Gamble stock in a transaction on Wednesday, August 28th. The stock was sold at an average price of $168.89, for a total transaction of $6,289,463.60. Following the sale, the chief executive officer now directly owns 263,537 shares in the company, valued at $44,508,763.93. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 313,597 shares of company stock valued at $53,268,499. 0.18% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
Several equities analysts have issued reports on PG shares. Piper Sandler began coverage on Procter & Gamble in a report on Tuesday, September 24th. They set a “neutral” rating and a $174.00 price objective on the stock. JPMorgan Chase & Co. lifted their price target on Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a research report on Thursday, September 19th. Jefferies Financial Group downgraded Procter & Gamble from a “buy” rating to a “hold” rating and decreased their price objective for the company from $182.00 to $175.00 in a report on Wednesday, July 24th. Deutsche Bank Aktiengesellschaft lifted their target price on shares of Procter & Gamble from $171.00 to $176.00 and gave the company a “buy” rating in a report on Wednesday, July 17th. Finally, Dbs Bank cut shares of Procter & Gamble from a “strong-buy” rating to a “hold” rating in a research note on Thursday, August 1st. Nine research analysts have rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average target price of $177.00.
Get Our Latest Report on Procter & Gamble
Procter & Gamble Company Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
See Also
- Five stocks we like better than Procter & Gamble
- How to Calculate Options Profits
- How Altimmune Could Grab a Big Chunk of the GLP-1 Market
- Consumer Staples Stocks, Explained
- Here’s Why Etsy Management Is Investing $1 Billion in Buybacks
- 3 Healthcare Dividend Stocks to Buy
- 3 Stocks Poised to Ride America’s Manufacturing and Ag Revival
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.